Kahu Team

It takes a flock of passionate technologists & researchers to bring a medical device to life. Come meet our friendly and professional team who are driven to make a difference!

Stuart has 15+ years in SaaS & entrepreneurship including former Head of Sales (ASX: JAN) & Head of Product (Nasdaq: HSIC) roles.
Chief Executive Officer
Stuart Dalrymple
Yaniv has 20+ years in bringing technology from research to commercialisation and has played a key role in building world-leading technologies in various fields, with focus on A.I.
Chief Technology Officer
Yaniv Gal
Kerry is an experienced C++ & Python developer, having worked on successful complex projects involving image processing, machine vision and algorithm performance.
A.I. Software Engineer
Kerry Carlyle
Thomas has 5+ years of experience in modelling and analysing data of biological origin, and has played a key role in getting a genetic diagnostic test for melanoma metastasis approved for reimbursement through Medicare at SkylineDx.
Health Data Scientist
Thomas Rademaker
Shravani is a passionate ISTQB Certified Quality Assuarance professional with over 10+ years in testing roles across automation, system testing, integration and performance and load testing.
Test Analyst
Shravani Beri
Jodi Mitchell
Jodi has had 20+ years experience in general management, software development and systems integration, having worked with a wide range of organisations and sectors providing technology solutions to both public and commercial organisations.
Liesl MacDonald
Liesl has a background in managing investment, value creation and M&A for growth companies. She oversees the Kāhu investment for the majority shareholder Pioneer Capital and is also a director for Molemap and Lifestream.
Kelvin Hyland
Kelvin is an experienced medical and healthcare senior executive.
The Kāhu team are supported by incredible group of Directors and Advisors who are experts in their fields. Together with our leadership team, our Advisory Group ensures Kāhu leverages the best thinking across technology, research and commercialisation.
Board of Directors
Dr Amandeep is a practicing GP @ Bondi Doctors, with experience in all things Clinical, Health and Digital.
Dr Amandeep Hansra
Putting data and digital best to work to support people and those who care for them live longer, healthier lives.
Tim Kelsey
Dr Martin Haskett
Dr Martin is a career Dermatologist who helped bring Molemap Ltd. to Australian shores some 20 years ago.
Scientific Advisory
Commercial Advisory
Prof. Peter is a world leader in Academic Dermatology with an astonishing 650 publications (<140 in last 5 years), and
author of 6 Dermatology books.
Brian has a background in clinical decision support solutions and venture backed technology business.
Adrian is the original entrepreneur and founder of MoleMap, Australia’s leading skin cancer screening clinic network.
Prof. Scott is a thought leader in the Dermatology community, author of 5 Dermatology books, 120+ citations and winner of multiple research awards.
Dr Niyati is Chief Medical Officer (CMO) of MoleMap Ltd. and founder of InsideOut, the first plantbased dermatology clinic in Australia.
Professor Peter Soyer
Brian Russel
Adrian Bowling
Professor Scott Menzies
Dr. Niyati Sharma
Stuart has 15+ years in SaaS & entrepreneurship including former Head of Sales (ASX: JAN) & Head of Product (Nasdaq: HSIC) roles. He has played key roles in launching and growing new SaaS products, as well as leading innovation projects and new business units. Stuart enjoys coaching & building high-performing teams and runs a career-development podcast. Stuart is a Computer Science / Software Engineering graduate and has an MBA from Melbourne Business School.
“It doesn’t get much better than leading a team of incredibly smart people help make a dent in the universe. We all believe this technology will change how skin cancer is discovered and diagnosed into the future. If we can save just one person’s life, it will be worth it. With Kāhu, we have the potential to do that and so much more.”
Stuart Dalrymple
General Manager
Yaniv has 20+ years in bringing technology from research to commercialisation and has played a key role in building world-leading technologies in various fields, with focus on A.I. His most recent roles include: CTO at Biolumic, A.I. Director at Ohmio Automotion, Research Program Manager at Compac Sorting, and an advisor for various tech start-ups. Yaniv holds a PhD in Electrical Engineering from the University of Queensland and is an author of dozens of academic papers and patents.
“It is not very often that one has the opportunity to be part of the development of a state-of-the-art technology that also has the potential to save lives and make large-scale impact. Kāhu is one of these unique opportunities.”
Yaniv Gal
Chief Technology Officer
Shravani is a passionate ISTQB Certified Quality Assuarance professional with over 10+ years in testing roles across automation, system testing, integration and performance and load testing.

"It means so much to me to be working on a company like this that aims to save lives. I'm driven to do my best everyday to help more patients be diagnosed earlier and treated."
Shravani Beri
Test Analyst
Thomas has 5+ years of experience in modelling and analysing data of biological origin, and has played a key role in getting a genetic diagnostic test for melanoma metastasis approved for reimbursement through Medicare at SkylineDx. He enjoys extracting signals and communicating insights from large datasets to make a difference in the real world. Thomas holds a PhD in Physics from McGill University.
"Working alongside dedicated professionals with access to the world’s largest database of high-quality, standardised skin lesion images, I am motivated to contribute to Kahu’s research program to revolutionise the standard of care in skin cancer diagnosis.“
Thomas Rademaker
Health Data Scientist
Kerry is an experienced C++ & Python developer, having worked on successful complex projects involving image processing, machine vision and algorithm performance. Kerry enjoys being part of a high-performing team and utilising his skills on both software and hardware development to bring real world change.
Kerry Carlyle
A.I. Software Engineer
Jodi has had 20+ years experience in general management, software development and systems integration, having worked with a wide range of organisations and sectors providing technology solutions to both public and commercial organisations. Jodi was CEO of Simpl Group for over 4 years, a New Zealand based company specialising in collaborating with others to deliver technology solutions that share information between organisations. Jodi’s passion for information technology is demonstrated by her being the Chair of NZ Health IT (2008-2017), which speak to her humble beginners as a programmer. Jodi’s speciality areas include business management, leadership, governance, sales management, client and partner management, financial management, and technology strategy. Her passion is working with teams to deliver enabling technology to improve a customer's business.
Jodi Mitchell
Liesl has a background in managing investment, value creation and M&A for growth companies. She oversees the Kāhu investment for the majority shareholder Pioneer Capital and is also a director for Molemap and Lifestream. Prior roles included M&A manager and strategy analyst for a multinational and Deloitte corporate finance advisory. Liesl holds a BCom (Finance) and DipGrad (Finance, Economics) from the University of Otago and CFA (level 3 candidate).
“I want to live in a world where the best skin cancer management is easy to access, affordable, and available immediately. We are excited to enable this transition from humble beginnings in skin surveillance to a scalable high performing medical device, so that no skin cancer goes undetected.”
Liesl MacDonald
Dr Martin is a career Dermatologist who helped bring Molemap Ltd. to Australian shores some 20 years ago. Dr. Martin is the co-author of 8 Dermatology publications, including (but not limited to) work on dermascopic analysis of merkel cell carcinoma, dermatoscopy aids in the diagnosis of basal cell carcinoma and the clinical and dermoscopic characteristics of merkal cell carcinoma. Dr Martin has been featured on 60-minutes, discussing his passion and belief in the ability for technology to help health care professionals discovery and diagnose skin cancer.
Dr Martin Haskett
Kelvin is an experienced medical and healthcare senior executive. Currently Managing Director for Ossis Ltd. - a MedTech company that has designed and manufactured patient-specific orthopaedic implants for over 12 years. Kelvin is also former GM of EBOS Healthcare, a medical device & supply company with ~45% markert share in Australia & New Zealand.
Kelvin Hyland
Dr Amandeep is a practicing GP @ Bondi Doctors, with experience in all things Clinical, Health and Digital. Entrepreneurship, Digital Health, Telemedicine, eHealth, Health Tech Start-ups, General Practice, Angel investing, Occupational medicine, Travel medicine, Aboriginal Health, Refugee Health, Aviation Medicine. Dr Amandeep also has an MBA from University of Sydney Business School.
Dr Amandeep Hansra
Putting data and digital best to work to support people and those who care for them live longer, healthier lives. Tim is CEO of Beamtree (ASX: BMT) - an international pioneer in health data analytics. Beamtree is an Australian Healthcare company that works with health organisations around the world to better capture, manage and leverage their human expertise to improve the performance of their business and deliver better patient outcomes. Tim is also a co-author with Roger Taylor of ‘Transparency and the Open Society’ which was published by Policy Press and the University of Chicago in 2016 and a visiting professor at the Institute for Global Health Innovation, Imperial College, London. Tim is a graduate of the Australian Institute of Company Directors (GAICD).
Tim Kelsey
Prof. Peter is a world leader in Academic Dermatology with an astonishing 650 publications (<140 in last 5 years), and author of 6 Dermatology books. Peter is the Chair & Director of Dermatology Research Centre (University Queensland), the University of Queensland Diamantina Institute, and Director Princess Alexandra Hospital Dermatology Department. He is a dermatologist with particular expertise in dermato-oncology and dermatologic imaging. His research group’s main focus is skin cancer, both melanoma and keratinocyte skin cancer. He established and is co-leader of the Australian Skin and Skin Cancer Research Centre, a joint collaboration between The University of Queensland and QIMR Berghofer Medical Research Institute. He is lead investigator of the NHMRC Centre of Research Excellence for the Study of Naevi and also leads the Australian Cancer Research Foundation (ACRF) Australian Centre of Excellence in Melanoma Imaging and Diagnosis (ACEMID). He is a Medical Research Future Fund (MRFF) Next Generation Clinical Researchers Program Practitioner Fellowship (2018-2022), and a Fellow of the Australian Academy of Health and Medical Sciences (AAHMS).Kelvin is an experienced medical and healthcare senior executive. Currently Managing Director for Ossis Ltd. - a MedTech company that has designed and manufactured patient-specific orthopaedic implants for over 12 years. Kelvin is also former GM of EBOS Healthcare, a medical device & supply company with ~45% markert share in Australia & New Zealand.
Professor Peter Soyer
Prof. Scott is a thought leader in the Dermatology community, author of 5 Dermatology books, 120+ citations and winner of multiple research awards. Prof. Scott is a lecturer @ University of Sydney and Member of Australian Centre of Excellence in Melanoma Imaging & Diagnosis.
Professor Scott Menzies
Dr Niyati is Chief Medical Officer (CMO) of MoleMap Ltd. and founder of InsideOut, the first plantbased dermatology clinic in Australia. Dr Niyati is an Adjunct Lecturer at Monash University with a Masters of Public Health (Human Nutritiion & Epidemiology). With a keen interest in skin health and public healthcare, Dr Niyati has also performed volunterring work over many years, doing Dermatology field work for people in need in East Timor, India & Papua New Guinea.
Dr. Niyati Sharma
Brian has a background in clinical decision support solutions and venture backed technology business. He is a technology strategist, board member on several technology companies and researches artificial intelligence applied to clinical decision support tools for NASA. Brian holds a PhD (AI and Physiology) from Auckland University of Technology and BE (Electrical and Engineering) from University of Auckland.
"Augmenting every clinical decision with years of specialist experience is getting closer. Doing it in an authentic and scalable way to change peoples lives is an awesome mission to be taking part in. “
Brian Russel
Adrian is the original entrepreneur and founder of MoleMap, Australia’s leading skin cancer screening clinic network. With over 25 years in the Dermatology Clinics, Adrian is a pioneer for skin health and reducing the impact of skin cancer. Adrian is a graduate of Engineeing (Chemical) and has an MBA from University of Auckland.
Adrian Bowling